"We are delighted to welcome Dr. Talreja as our newly appointed Medical Advisor," said Helen Ljungdahl Round, Acarix President and CEO. "His deep understanding of cardiac patient care, preventive cardiology and dedication to improving healthcare aligns perfectly with our vision. With Dr. Talreja's guidance and input, we are confident in our ability to advance our mission of transforming early cardiac diagnostics for clinicians and their patients, ultimately leading to better patient care and outcomes."

"I am honored to join the Acarix team as their Medical Advisor," said Dr. Deepak Talreja, Sentara Health Medical Director of the Cardiovascular Service Line. "Acarix's mission to transform early cardiac diagnostics with the CADScor System supports my goal of improving patient outcomes by detecting coronary disease early and enabling timely intervention if required. I am excited to contribute my knowledge and expertise to the team. I look forward to working collaboratively to enhance the quality of patient care in the United States."

As a highly respected cardiologist expert, Dr. Talreja has been at the forefront of numerous groundbreaking research initiatives, pioneering advancements that have significantly impacted patient care and outcomes. He is a graduate of the University of Virginia School of Medicine, completed his Internship and Residency at Vanderbilt University Medical Center, and fellowship at the Mayo School of Medicine. Dr. Talreja is board certified by the American Board of Internal Medicine (ABIM) in cardiovascular disease, interventional cardiology, and internal medicine: He is currently the Medical Director of the Cardiovascular Service Line at Sentara Health. Dr. Talreja's vast experience and leadership experience in cardiac electrical system procedures, interventional cardiac procedures, heart conditions and overall cardiac patient care align very well with Acarix's mission to develop patient-focused innovative solutions that address some of the challenges in early cardiac healthcare.